4D Molecular Therapeutics (FDMT) Earnings Date & Reports

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FDMT is expected to report earnings to -103 cents per share on November 11

4D Molecular Therapeutics FDMT Stock Earnings Reports

Q3'26

Est.

$-1.04

Q2'26

Missed

by $0.03

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.96

Q3'25

Est.

$-1.01

The last earnings report on August 13 showed earnings per share of -103 cents, missing the estimate of -100 cents. With 505.64K shares outstanding, the current market capitalization sits at 874.52M.

View a ticker or compare two or three

Ask AI

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

FDMT

Setup

Daily Signal:

Description

Gain/Loss: